Director of Department of Screening and Cell Technology, Biopharmaceuticals Research Unit, Novo Nordisk, Denmark.
Current key responsibilities include design and implementation of efficient and robust screening assays to select and characterize therapeutic protein candidates in a broad span of haemophilia and inflammation projects within the Biopharmaceuticals Research Unit at Novo Nordisk.
Previous professional experience includes 15 years of employment within research in biopharmaceutical industry as research scientist, principal scientist and project manager. Holds a Ph.D. in Biochemistry and Molecular Biology from University of Odense, Denmark, of which initial part was conducted at Karolinska Institute, Stockholm, Sweden